NeuroMetrix, Inc. short interest in 2021
In 2021, NeuroMetrix, Inc.'s disclosed short interest ran from 3.50% of shares outstanding on 15 Jan 2021 to 1.63% on 31 Dec 2021, a change of -1.87 percentage points. The year's high was 22.76% on 30 Jul 2021 and its low 0.39% on 12 Feb 2021, averaging 4.51% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.00 days on 15 Jan 2021. Full history: NeuroMetrix, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024
2021 in figures
- Start of year
- 3.50% (15 Jan 2021)
- End of year
- 1.63% (31 Dec 2021)
- Change
- -1.87 pp
- High
- 22.76% (30 Jul 2021)
- Low
- 0.39% (12 Feb 2021)
- Average
- 4.51%
- Highest days to cover
- 1.00 (15 Jan 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 3.50% | 1.00 | |
| 29 Jan 2021 | 0.68% | 1.00 | results (8-K), 10-K filed |
| 12 Feb 2021 | 0.39% | 1.00 | |
| 15 Mar 2021 | 0.78% | 1.00 | |
| 31 Mar 2021 | 0.62% | 1.00 | |
| 15 Apr 2021 | 0.69% | 1.00 | |
| 30 Apr 2021 | 1.12% | 1.00 | 10-Q filed, results (8-K) |
| 14 May 2021 | 1.93% | 1.00 | |
| 28 May 2021 | 1.12% | 1.00 | |
| 15 Jun 2021 | 0.95% | 1.00 | |
| 30 Jun 2021 | 0.89% | 1.00 | |
| 15 Jul 2021 | 0.80% | 1.00 | |
| 30 Jul 2021 | 22.76% | 1.00 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 20.24% | 1.00 | |
| 30 Sep 2021 | 9.34% | 1.00 | |
| 15 Oct 2021 | 10.96% | 1.00 | |
| 29 Oct 2021 | 5.70% | 1.00 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 3.83% | 1.00 | |
| 15 Dec 2021 | 2.31% | 1.00 | |
| 31 Dec 2021 | 1.63% | 1.00 |
See also: NeuroMetrix, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.